IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients

BACKGROUND: A very small proportion of patients diagnosed with glioblastoma (GBM) survive more than 3 years. Isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations define a small subgroup of GBM patients with favourable prognosis. However, it remains controversial whether long-term survivors (LTS) are f...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Amelot, Aymeric, De Cremoux, Patricia, Quillien, Véronique, Polivka, Marc, Adle-Biassette, Homa, Lehmann-Che, Jacqueline, Françoise, Laurence, Carpentier, Antoine F., George, Bernard, Mandonnet, Emmanuel, Froelich, Sébastien
格式: Artigo
語言:Inglês
出版: Public Library of Science 2015
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4497660/
https://ncbi.nlm.nih.gov/pubmed/26158269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0130596
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍